Formula I Compounds Targeting Cell Cycle Phases for Cancer Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current chemotherapeutics are ineffective as they only target a small portion of cells during the cell division cycle, with most cancer cells being in the Go phase, limiting their therapeutic impact.
Innovation Solution
Compounds of Formula I, which interfere with DNA synthesis by binding to amino acids, are administered to target cancer cells and viral infections, effectively treating cancer and viral infections by disrupting cell cycle progression.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current chemotherapeutics are used to treat cancer, then they can kill some dividing cells, but they are ineffective against the majority of cells in the Go phase
Solution Approach 1:
The compound of Formula I is designed to function across all phases of the cell cycle, not just specific phases. By targeting DNA synthesis through amino acid binding, it achieves universal activity against cells in Go phase, S phase, and other division phases, making the treatment versatile across different cell states
Solution Approach 2:
The invention changes the mechanism parameter from phase-specific targeting to phase-independent DNA synthesis inhibition. By altering the molecular mechanism to bind amino acids and interfere with DNA synthesis universally, the compound achieves effective treatment across all cell cycle phases
2Productivity
If chemotherapeutics target only a small time zone during cell division, then they have limited side effects, but their cell kill rate is only 2-5% which is insufficient
Solution Approach 1:
The compound of Formula I maintains continuous therapeutic action by inhibiting DNA synthesis throughout the entire cell cycle. Unlike phase-specific drugs that act only during certain windows, this compound continuously interferes with amino acid binding and DNA synthesis, achieving sustained cell kill rates exceeding 2-5% across all cell states
3Measurement precision
If DNA synthesis is directly related to the speed of cell cycle, then faster dividing cells incorporate more amino acids, but current drugs cannot effectively target slower dividing cells in Go phase
Solution Approach 1:
The compound achieves universal targeting across cell types with different division speeds by binding to amino acids involved in DNA synthesis. This mechanism works whether cells are dividing rapidly or are in Go phase, making the treatment adaptable to various cell types including solid tumors, lymphomas, and leukemias
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The compounds achieve significant cell kill and inhibit viral replication by targeting cells throughout the cell cycle, including the Go phase, leading to effective treatment of cancer and viral infections.
Implementation Method 1
By binding to amino acids, the compounds of the present application interfere with DNA synthesis
Data Source
AI summary
The present application relates to the use of one or more compounds of Formula (I) or pharmaceutically acceptable solvates or prodrugs thereof, for treating cancer or for treating or preventing a viral infection.